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Correlation of DEFA1 Gene Copy Number Variation with 
Intestinal Involvement in Behcet’s Disease
Copy number variation has been associated with various autoimmune diseases. We 
investigated the copy number (CN) of the DEFA1 gene encoding α–defensin-1 in samples 
from Korean individuals with Behcet’s disease (BD) compared to healthy controls (HC). We 
recruited 55 BD patients and 35 HC. A duplex Taqman® real-time PCR assay was used to 
assess CN. Most samples (31.1%) had a CN of 5 with a mean CN of 5.4 ± 0.2. There was 
no significant difference in the CN of the DEFA1 gene between BD patients and HC. A high 
DEFA1 gene CN was significantly associated with intestinal involvement in BD patients. 
Variable DEFA1 gene CNs were observed in both BD patients and HC and a high DEFA1 
gene CN may be associated with susceptibility to intestinal involvement in BD.
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Behcet’s disease (BD) is a chronic, systemic vasculitis of un-
known etiology, characterized by orogenital ulcers, uveitis, and 
arthritis, and is most prevalent in Korea, China, Japan and Tur-
key (1). Although the pathogenesis of BD remains unknown, 
several lines of evidence have suggested that host genetic fac-
tors play a pivotal role in determining susceptibility to BD (2-4). 
  Copy number variation (CNV) is defined as deletions or du-
plications of DNA segments larger than 1 kilobase and up to sev-
eral megabases in size that are present in variable copy num-
bers compared to a reference genome (5). Such duplications or 
deletions of genes or regions that control specific gene expres-
sion would be likely to influence protein expression. Conse-
quently, CNV may influence the susceptibility to diseases or the 
response to environmental factors. CNV has been associated with 
complex disease traits, such as susceptibility to systemic lupus 
erythematosus (SLE), and rheumatoid arthritis (RA) (6-8).
  Previous studies reported that trisomy 8 is associated with 
severe and full-blown manifestations, such as intestinal ulcer-
ation and high fever, in BD patients with bone marrow failure 
(BMF) (2, 9). It was suggested that one of the candidate genes of 
chromosome 8 may be implicated in the pathogenesis of BD. 
  Neutrophils play a central role in the innate immunity and 
are known to be hyperactive in BD (1, 10). They possess a set of 
granules that contain many antimicrobial peptides, including 
defensins. Genes of defensins are located in a cluster on chro-
mosome 8 and encode antimicrobial peptides that play a role 
in innate immunity (11). Defensins consist of three main sub-
families, α-, β and θ-defensins and α–defensins are released into 
the extracellular milieu from neutrophils during inflammation, 
resulting in induction and aggravation of inflammatory reac-
tions (11). 
  From these findings, it was inferred that the copy number (CN) 
of the DEFA1 gene may influence the development or aggrava-
tion of clinical manifestations in BD patients. To test this hypoth-
esis, we investigated the CN of the DEFA1 gene in samples from 
Korean individuals with BD.
  The experimental protocols used in this study were approved 
by the institutional review board of the Kangbuk Samsung Hos-
pital (#KBC10108). Informed consent was obtained from all BD 
patients and healthy volunteers. For CNV analysis, 55 samples 
(34 men, 21 women) from Korean BD patients and 35 ethnical-
ly-matched control samples (10 men, 25 women) were recruit-
ed. Patients fulfilled the diagnostic criteria of the international 
BD study group (12). Healthy control subjects were medically 
healthy by history and examination. Of those, we also excluded 
the subjects with BD related symptoms such as oral or genital Ahn JK, et al.  •  DEFA1 Gene Copy Number Variation in Behcet’s Disease
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ulceration. The demographic and clinical data were obtained 
from the medical records of patients.
  Gene CN was determined by a duplex Taqman
® real-time PCR 
assay (Applied Biosystems, Foster City, CA, USA) following the 
manufacturer’s instructions. The gene CN assay was run as a du-
plex Taqman
® real-time PCR reaction with the RNase P gene as 
a reference gene. The 10 μL reaction mixture consisted of 5 μL 
(2 ×) Taqman
® universal PCR mastermix, 0.1 mL Amplitaq Gold, 
2.5 μL dH2O, 0.7 μL RNase P primer/probe mastermix (22.5 μM 
primers and 5 μM probe), 0.7 μL DEFA1 primer/probe master-
mix (5.63 μM primers and 1.25 μM probe; Forward: 5´-GGAT-
GTCCGCTGCAATCTG-3´, Reverse: 5´-GCCATCCTTGCTGCC-
ATTC-3´; FAM Reporter: 5´-CAGCAACCTCATCAGCTCTT-3´) 
and 15 ng DNA (1 μL). Using a standard curve for each gene, the 
number of DEFA1 copies was calculated as the relative relation-
ship between the signals from DEFA1 and the reference gene. 
The number of copies of the DEFA1 gene sequence in each test 
sample was determined by relative quantitation using the com-
parative CT (ΔΔCT) method. This method measured the CT dif-
ference (ΔCT) between target and reference sequences and then 
compared the ΔCT values of test samples to a calibrator sample 
known to have two copies of the target sequence. All samples 
were analyzed in triplicate. Relative quantitation analysis was 
performed using CopyCaller
TM Software (Applied Biosystems). 
  Statistical comparison between the groups was performed us-
ing Student’s t-test, and chi-squared-test. Logistic regression 
analyses were performed to estimate the odds ratio (OR) adjusted 
for age and sex. P values less than 0.05 were considered statisti-
cally significant. The PASW statistics software package (version 
17.0, SPSS Institute, Chicago, IL, USA) was used for all analyses. 
  The mean ages (± standard deviation) of BD patients and 
healthy controls were 44.2 (± 9.3) and 45.2 (± 12.9) yr, respec-
tively. Among BD patients, erythema nodosum was the second 
most common clinical finding (63.6% of patients), followed by 
genital ulcers (61.8%), arthritis (40.0%), vascular involvement 
(36.3%), ocular involvement (23.6%), and intestinal involvement 
(10.9%). 
  Overall, most samples (31.1%) had a CN of 5 with a mean CN 
of 5.4 ± 0.2. There was no significant difference in the DEFA1 CN 
between BD patients and healthy control subjects (mean CN 
5.3 ± 0.2 vs 5.5 ± 0.3 copies, P = 0.883, Fig. 1). There was no sig-
nificant difference in DEFA1 CN between male BD patients and 
healthy male controls (P = 0.956) or between female BD patients 
and healthy female controls (P = 0.505). There was no signifi-
cant association between the DEFA1 gene CN and clinical fea-
tures (Table 1). However, we found that a high DEFA1 CN was 
significantly associated with intestinal involvement in BD pa-
tients (OR = 2.86, 95% confidence interval 1.37-5.94, P = 0.005). 
Intestinal involvement was found in six patients with BD, who 
had 5, 6, 7, 8, 9, and 10 copies of the DEFA1 gene, respectively. 
In our experiment, three BD patients had complications of BMF, 
trisomy 8 in their bone marrow and intestinal involvement, and 
their copy number was 6, 7, and 9 copies, respectively. 
  Host genetic factors are thought to influence susceptibility   
to BD. Behcet’s disease, also known as the Silk Road disease, is 
strongly associated with HLA-B51 (4). It was reported that the 
higher concordance rate of monozygotic twins compared to di-
zygotic twins suggests significant genetic influences on the de-
velopment of BD (3). We previously reported that intestinal in-
volvement and full-blown features of BD were common in pa-
tients with BMF who had trisomy 8 in their bone marrow (2), sug-
gesting that candidate genes associated with the development 
of BD may be located on chromosome 8. Defensin genes form 
a cluster at 8p23 and CNs of DEFA1 gene and seven β-defensin 
genes on chromosome 8 are known to vary in normal subjects 
(8, 13, 14). α-defensin-1 is the most abundant isoform of α-de-
fensins in neutrophil granules. Since the DEFA1 gene encoding 
α-defensin-1 on chromosome 8 was a possible candidate con-
tributing to the risk of BD, we examined the CNV of the DEFA1 
gene in BD patients compared with healthy controls, and sought 
to determine the association between the CN of the DEFA1 gene 
and clinical BD phenotypes. 
  As shown in Fig. 1, we found that the DEFA1 gene showed 
common CNV between 2 and 9 copies per diploid cell in BD 
patients and healthy controls, with occasionally CNs as high as 
10 in BD patients. Our results showed that the DEFA1 gene CN 
Table 1. The relationship between DEFA1 gene copy numbers and clinical phenotypes
Clinical phenotypes OR 95% CI P value
Genital ulcer 1.16 0.82-1.65 0.404
Erythema nodosum 0.86 0.62-1.20 0.379
Positive Pathergy test 0.44 0.17-1.13 0.087
Vascular involvement 0.77 0.52-1.13 0.185
Ocular involvement 0.90 0.59-1.35 0.596
Articular involvement 0.94 0.65-1.36 0.730
Intestinal involvement 2.86 1.37-5.94 0.005
CNS involvement 1.00 0.46-2.15 0.979
CNS, central nervous system; OR, odds ratio; CI, confidence interval.
Fig. 1. Copy numbers of the DEFA1 gene encoding α-defensin-1 in 55 Koreans with 
Behcet’s disease and 35 ethnically-matched healthy controls. 
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was not significantly different between BD patients and healthy 
controls. A similar report found that the mean copy number for 
α-defensins gene among 14 BD patients (mean CN of 5.1 copies) 
was not significantly different compared to the 121 unaffected 
controls (mean CN of 6.8 copies) in the UK (9). In accordance 
with previous studies (9, 13), the DEFA1 gene in our samples 
appeared to be present in high CNs in both Korean patients with 
BD and healthy controls, and no significant difference in the 
DEFA1 CN was observed between the two groups. Our study 
demonstrated that a higher DEFA1 gene CN was significantly 
associated with BD patients with intestinal involvement com-
pared to those without intestinal involvement, suggesting that  
a high DEFA1 CN may contribute to intestinal involvement in 
BD patients. High CNs of DEFA1 gene were closely related to the 
level of α-defensin-1 expression (14). α-defensins confer not only 
antimicrobial effects such as microbicidal or antiviral activity, 
but also have an immune-enhancing or cytokines-inducing ef-
fect similar to that of tumor necrosis factor-α and interleukin-1 
(15, 16). Also, α- and β-defensins are important in immune acti-
vation in the epithelial surface (11). From these findings, it is con-
ceivable that the high CN of the DEFA1 gene and the subsequent 
increase in α-defensin-1 expression might initiate or amplify the 
inflammatory reaction in the intestine of BD patients. Accord-
ingly, high DEFA1 gene CN may be associated with susceptibil-
ity to intestinal involvement in patients with BD. Similar to the 
present results, it was recently reported that high α-defensins 
CN is significantly linked to the inflammation of colonic Crohn’s 
disease (17). Some authors have reported that inflammatory 
bowel disease (IBD) and BD may be part of a spectrum of dis-
ease rather than distinct disease entities (18). Considering these 
findings, α-defensins CNV may be one of the pathogenic mech-
anisms common to development of IBD and intestinal BD. 
  BD patients with positive pathergy tests had lower DEFA1 CNs 
than those with negative tests, although this difference was not 
statistically significant. Considering the fact that neutrophil in-
filtration and activation are increased in pathergy reactions, or 
pustules (19), our result was unexpected. We note that our find-
ing may be partly due to the small number of patients in each of 
our study groups. 
  In conclusion, variable CNs of the DEFA1 gene have been ob-
served in both BD patients and healthy controls and high DEFA1 
CNs may be associated with susceptibility to intestinal involve-
ment in BD. Further studies will be required to determine the 
reproducibility of our findings in larger patient groups and dif-
ferent study populations.  
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